blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2144617

EP2144617 - DELIVERY OF FLU ANTIBODIES TO SURFACES IN CONTACT WITH AIR [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  06.03.2015
Database last updated on 14.09.2024
Most recent event   Tooltip06.03.2015Application deemed to be withdrawnpublished on 08.04.2015  [2015/15]
Applicant(s)For all designated states
Immuron Limited
Level 1 39 Leveson Street
North Melbourne, Victoria 3051 / AU
[2010/03]
Inventor(s)01 / RAWLIN, Grant, Thomas
43 O'Gradys Road
Kilmore East, Victoria 3764 / AU
02 / LICHTI, Gottfried
PO Box 322
Moonee Ponds, Victoria 3039 / AU
03 / ROBINS-BROWNE, Roy, Michael
5 Oxford Close
Templestowe, Victoria 3106 / AU
 [2010/03]
Representative(s)Bewley, Ewan Stuart, et al
Ipulse
4 Bloomsbury Place
London WC1A 2QA / GB
[N/P]
Former [2014/24]Rickard, David John, et al
Ipulse
26 Mallinson Road
London SW11 1BP / GB
Former [2010/51]Murphy, Colm Damien, et al
Ipulse 26 Mallinson Road London
SW11 1BP / GB
Former [2010/03]Murphy, Colm Damien, et al
Ipulse 26 Mallinson Road London
SW11 1BP / GB
Application number, filing date08733337.311.04.2008
[2010/03]
WO2008AU00509
Priority number, dateUS20070907621P11.04.2007         Original published format: US 907621 P
[2010/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008124870
Date:23.10.2008
Language:EN
[2008/43]
Type: A1 Application with search report 
No.:EP2144617
Date:20.01.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 23.10.2008 takes the place of the publication of the European patent application.
[2010/03]
Search report(s)International search report - published on:AU23.10.2008
(Supplementary) European search report - dispatched on:EP25.03.2011
ClassificationIPC:A61K35/20, A61K39/02, A61K39/145, A61P31/16
[2010/03]
CPC:
C07K16/04 (EP,US); A61K35/20 (EP,US); A61K39/12 (EP,US);
A61K39/145 (EP,US); A61K9/0075 (EP,US); A61P31/16 (EP);
C07K16/1018 (EP,US); A61K2039/5252 (EP,US); A61K2039/55566 (EP,US);
A61K9/12 (EP,US); C12N2760/16134 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/03]
TitleGerman:FREISETZUNG VON GRIPPEANTIKÖRPERN AUF OBERFLÄCHEN IN KONTAKT MIT LUFT[2010/03]
English:DELIVERY OF FLU ANTIBODIES TO SURFACES IN CONTACT WITH AIR[2010/03]
French:ADMINISTRATION D'ANTICORPS ANTIGRIPPAUX AU NIVEAU DE SURFACES EN CONTACT AVEC L'AIR[2010/03]
Entry into regional phase09.10.2009National basic fee paid 
09.10.2009Search fee paid 
09.10.2009Designation fee(s) paid 
09.10.2009Examination fee paid 
Examination procedure09.10.2009Examination requested  [2010/03]
18.10.2011Amendment by applicant (claims and/or description)
01.11.2014Application deemed to be withdrawn, date of legal effect  [2015/15]
27.11.2014Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2015/15]
Fees paidRenewal fee
30.04.2010Renewal fee patent year 03
28.04.2011Renewal fee patent year 04
25.04.2012Renewal fee patent year 05
14.06.2013Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.04.201306   M06   Fee paid on   14.06.2013
30.04.201407   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YP]WO2007134327  (SEA LANE BIOTECHNOLOGIES LLC [US], et al) [YP] 1-15 * the whole document *;
 [Y]  - MITCHELL G A ET AL, "Antibody production in milk serum after virus instillation of goat mammary gland. IV. Experiments with protective properties of specific influenza antibody associated with lactogammaglobulin.", CANADIAN JOURNAL OF COMPARATIVE MEDICINE. REVUE CANADIENNE DE MÉDECINE COMPARÉE JAN 1971 LNKD- PUBMED:4251415, (197101), vol. 35, no. 1, ISSN 0008-4050, pages 52 - 59, XP002623137 [Y] 1-15 * tables IV, V *
 [Y]  - SMITH DAN J ET AL, "Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus.", VACCINE 20 JUN 2003 LNKD- PUBMED:12798621, (20030620), vol. 21, no. 21-22, ISSN 0264-410X, pages 2805 - 2812, XP002622283 [Y] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1016/S0264-410X(03)00224-X
 [Y]  - LANGLEY JOANNE M ET AL, "Safety and immunogenicity of a Proteosome -trivalent inactivated influenza vaccine, given nasally to healthy adults.", VACCINE 6 MAR 2006 LNKD- PUBMED:16303215, (20060306), vol. 24, no. 10, ISSN 0264-410X, pages 1601 - 1608, XP002622284 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/J.VACCINE.2005.09.056
 [Y]  - BOT A I ET AL, "Receptor-mediated targeting of spray-dried lipid particles coformulated with immunoglobulin and loaded with a prototype vaccine.", PHARMACEUTICAL RESEARCH JUL 2001 LNKD- PUBMED:11496957, (200107), vol. 18, no. 7, ISSN 0724-8741, pages 971 - 979, XP002622285 [Y] 1-15 * the whole document *
 [Y]  - RAMISSE F ET AL, "Effective prophylaxis of influenza A virus pneumonia in mice by topical passive immunotherapy with polyvalent human immunoglobulins or F(ab')2 fragments.", CLINICAL AND EXPERIMENTAL IMMUNOLOGY MAR 1998 LNKD- PUBMED:9528903, (199803), vol. 111, no. 3, ISSN 0009-9104, pages 583 - 587, XP002622286 [Y] 1-15 * the whole document *
 [Y]  - OLIVARES MÓNICA ET AL, "Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination.", NUTRITION (BURBANK, LOS ANGELES COUNTY, CALIF.) MAR 2007 LNKD- PUBMED:17352961, (200703), vol. 23, no. 3, ISSN 0899-9007, pages 254 - 260, XP002622287 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/J.NUT.2007.01.004
 [Y]  - FAHY J V ET AL, "Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects.", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE SEP 1999 LNKD- PUBMED:10471635, (199909), vol. 160, no. 3, ISSN 1073-449X, pages 1023 - 1027, XP002623138 [Y] 1-15 * the whole document *
 [YP]  - MINNE A ET AL, "Intranasal delivery of whole influenza vaccine prevents subsequent allergen-induced sensitization and airway hyper-reactivity in mice.", CLINICAL AND EXPERIMENTAL ALLERGY : JOURNAL OF THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY AUG 2007 LNKD- PUBMED:17651156, (200708), vol. 37, no. 8, ISSN 0954-7894, pages 1250 - 1258, XP002622288 [YP] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1111/J.1365-2222.2007.02767.X
 [YP]  - MINNE ANTOINE ET AL, "The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response.", IMMUNOLOGY NOV 2007 LNKD- PUBMED:17521369, (200711), vol. 122, no. 3, ISSN 0019-2805, pages 316 - 325, XP002622289 [YP] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1111/j.1365-2567.2007.02641.X
International search[A]WO03080082  (ANADIS LTD [AU], et al);
 [A]WO2006053383  (ANADIS LTD [AU], et al);
 CN1965665  [ ] (JASON MEDICAL GROUP FAR EAST L [HK]);
 [A]  - JAKEMAN K.J. ET AL., "Mechanism of immunity to influenza: maternal and passive neonatal protection following immunization of adult ferrets with a live vaccinia-influenza virus haemagglutinin recombinant but not with recombinants containing other influenza virus proteins", JOURNAL OF GENERAL VIROLOGY, (198906), pages 1523 - 1531, XP001069248
 [A]  - WILSON W.D. ET AL., "Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination", EQUINE VETERINARY JOURNAL, (200111), vol. 33, no. 7, pages 644 - 650, XP008122785
 [A]  - YASUI H. ET AL., "Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064", CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, (199903), vol. 6, no. 2, pages 186 - 192, XP002288967
 [AP]  - CA, Database accession no. (147:52037), XP008114245
 [A]  - EYLES J.E. ET AL., "Intranasal administration of Influenza Vaccines: Current Status", BIODRUGS, (200001), vol. 13, no. 1, pages 35 - 59, XP009122294

DOI:   http://dx.doi.org/10.2165/00063030-200013010-00005
by applicant   - MITCHELL ET AL., CANADIAN JOURNAL OF COMPARATIVE MEDICINE, (197101), vol. 35, no. 1, pages 52 - 59
    - SMITH ET AL., VACCINE, vol. 21, no. 21-22, pages 2805 - 2812
    - LANGLEY ET AL., VACCINE, (20060306), vol. 24, no. 10, pages 1601 - 1 608
    - BOT ET AL., PHARMACEUTICAL RESEARCH, (200107), vol. 18, no. 7, pages 971 - 979
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.